3 Coronavirus Testing Stocks to Buy with Winter Approaching

This post was originally published on this site

In addition, as people travel back to their hometowns for Thanksgiving, cases have been increasing across the country, with more than 90,000 cases being reported each day and more than 30 states experiencing upticks.

Last month, it was announced that unvaccinated travelers entering the United States would face stricter restrictions, requiring them to produce a document indication they’ve had a recent negative COVID-19 test. So, this mandate should drive the revenues of coronavirus testing companies. Indeed, the global COVID-19 diagnostics market is expected to expand at a 3.1% CAGR between 2021 – 2027.

Continue reading on StockNews